Evidence map›Paper›PMID 32839523›Full record

ArticleScientific reports2020

Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models.

Peter Jianrui Liu, James M Harris, Emanuele Marchi, Valentina D'Arienzo, Thomas Michler, Peter A C Wing, Andrea Magri, Ana Maria Ortega-Prieto, Maarten van de Klundert, Jochen Wettengel and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Peter Jianrui Liu *Nuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK.
James M Harris *Nuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK.
Emanuele MarchiMedawar Building, University of Oxford, South Parks Road, Oxford, OX1 3SY, UK.
Valentina D'ArienzoNuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK.
Thomas MichlerInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Trogerstrasse 30, 81675, Munich, Germany.
Peter A C WingNuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK.
Andrea MagriNuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK.
Ana Maria Ortega-PrietoSection of Molecular Virology, Department of Infectious Diseases, Imperial College London, London, W2 1PG, UK.
Maarten van de KlundertInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Trogerstrasse 30, 81675, Munich, Germany.
Jochen WettengelInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Trogerstrasse 30, 81675, Munich, Germany.
David DurantelCancer Research Center of Lyon (CRCL), INSERM U1052, and University of Lyon (UCBL1), Lyon, France.
Marcus DornerSection of Molecular Virology, Department of Infectious Diseases, Imperial College London, London, W2 1PG, UK.
Paul KlenermanMedawar Building, University of Oxford, South Parks Road, Oxford, OX1 3SY, UK.
Ulrike ProtzerInstitute of Virology, Technical University of Munich/Helmholtz Zentrum München, Trogerstrasse 30, 81675, Munich, Germany.
Efstathios S GiotisSection of Molecular Virology, Department of Infectious Diseases, Imperial College London, London, W2 1PG, UK.
Jane A McKeatingNuffield Department of Medicine Research Building, University of Oxford, Oxford, OX3 7LF, UK. jane.mckeating@ndm.ox.ac.uk.
University of Oxford · GBImperial College London · GBHelmholtz Zentrum München · DEMedawar Building for Pathogen Research · GBTechnical University of Munich · DEUniversité Claude Bernard Lyon 1 · FR

Funding

Medical Research Council G0400802Medical Research Council G0801976Medical Research Council MR/R022011/1Wellcome Trust 104771/Z/14/ZWellcome Trust 109965/Z/15/ZWellcome Trust IA 200838/Z/16/ZWellcome Trust WT 109965MA
6 · The paper itself

Abstract

Hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC) worldwide. The prolyl hydroxylase domain (PHD)-hypoxia inducible factor (HIF) pathway is a key mammalian oxygen sensing pathway and is frequently perturbed by pathological states including infection and inflammation. We discovered a significant upregulation of hypoxia regulated gene transcripts in patients with chronic hepatitis B (CHB) in the absence of liver cirrhosis. We used state-of-the-art in vitro and in vivo HBV infection models to evaluate a role for HBV infection and the viral regulatory protein HBx to drive HIF-signalling. HBx had no significant impact on HIF expression or associated transcriptional activity under normoxic or hypoxic conditions. Furthermore, we found no evidence of hypoxia gene expression in HBV de novo infection, HBV infected human liver chimeric mice or transgenic mice with integrated HBV genome. Collectively, our data show clear evidence of hypoxia gene induction in CHB that is not recapitulated in existing models for acute HBV infection, suggesting a role for inflammatory mediators in promoting hypoxia gene expression.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorDisease Models, AnimalEndothelial PAS Domain-Containing Protein 1FemaleHepatitis B, ChronicHep G2 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesLiverLiver CirrhosisMaleMiceBasic Helix-Loop-Helix ProteinsEGLN1 protein, humanEndothelial PAS Domain-Containing Protein 1hepatitis B virus X proteinHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesOxygenTrans-ActivatorsViral Regulatory and Accessory Proteins

Identifiers

PMID32839523
PMCPMC7445281
OpenAlexW3047517210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.